SH2D2A Antikörper (Internal Region)
-
- Target Alle SH2D2A Antikörper anzeigen
- SH2D2A (SH2 Domain Protein 2A (SH2D2A))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SH2D2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- Affinity Chromatography
- Immunogen
- Synthesized peptide derived from the Internal region of human Lad.
- Isotyp
- IgG
- Top Product
- Discover our top product SH2D2A Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- SH2D2A (SH2 Domain Protein 2A (SH2D2A))
- Andere Bezeichnung
- SH2D2A (SH2D2A Produkte)
- Synonyme
- F2771 antikoerper, SCAP antikoerper, TSAD antikoerper, VRAP antikoerper, Lad antikoerper, Ribp antikoerper, Tsad antikoerper, SH2 domain containing 2A antikoerper, SH2D2A antikoerper, Sh2d2a antikoerper
- Gen-ID
- 9047
- UniProt
- Q9NP31
- Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
-